Autoimmune Cytopenias

This case study, reported in the Annals of Hematology as a Letter to the Editor, presents an 84-year-old man with COVID-19 and new onset warm autoimmune hemolytic anemia (wAIHA). In outlining best-practices patient management, the authors state that, “since glucocorticoids are also used in moderate to severe COVID-19 cases, it is reasonable to treat COVID-19-associated warm AIHA with glucocorticoids,” and note that it takes an average of 8 days from the first symptom of COVID-19 to the development of wAIHA.